Target- |
MechanismImmunomodulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date31 Jan 2020 |
100 Clinical Results associated with Aimmune Therapeutics Ireland Ltd.
0 Patents (Medical) associated with Aimmune Therapeutics Ireland Ltd.
100 Deals associated with Aimmune Therapeutics Ireland Ltd.
100 Translational Medicine associated with Aimmune Therapeutics Ireland Ltd.